TEODORI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.972
EU - Europa 11.799
AS - Asia 7.939
SA - Sud America 807
AF - Africa 223
OC - Oceania 141
Continente sconosciuto - Info sul continente non disponibili 4
Totale 37.885
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.767
RU - Federazione Russa 3.641
SG - Singapore 2.307
IT - Italia 2.279
CN - Cina 1.904
PL - Polonia 1.615
HK - Hong Kong 1.233
IE - Irlanda 1.028
SE - Svezia 957
VN - Vietnam 870
KR - Corea 714
BR - Brasile 643
DE - Germania 545
FI - Finlandia 414
UA - Ucraina 383
FR - Francia 322
IN - India 275
GB - Regno Unito 259
JP - Giappone 153
AU - Australia 139
CA - Canada 115
CH - Svizzera 86
BD - Bangladesh 75
TR - Turchia 70
NL - Olanda 65
AR - Argentina 59
ES - Italia 59
JO - Giordania 59
ID - Indonesia 54
MX - Messico 52
CI - Costa d'Avorio 49
IQ - Iraq 49
ZA - Sudafrica 45
BE - Belgio 42
CO - Colombia 29
PK - Pakistan 25
NG - Nigeria 24
EC - Ecuador 19
RO - Romania 19
VE - Venezuela 18
MA - Marocco 17
SC - Seychelles 17
UZ - Uzbekistan 16
CL - Cile 15
AZ - Azerbaigian 13
SA - Arabia Saudita 13
AT - Austria 12
DZ - Algeria 12
KE - Kenya 11
LT - Lituania 11
PH - Filippine 11
PY - Paraguay 11
TN - Tunisia 11
BJ - Benin 10
CZ - Repubblica Ceca 10
HU - Ungheria 10
TH - Thailandia 10
TW - Taiwan 10
EG - Egitto 9
IL - Israele 8
MY - Malesia 8
NP - Nepal 8
LB - Libano 7
CR - Costa Rica 6
JM - Giamaica 6
KZ - Kazakistan 6
PE - Perù 6
PT - Portogallo 6
SN - Senegal 6
DK - Danimarca 5
HR - Croazia 5
NI - Nicaragua 5
OM - Oman 5
AM - Armenia 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
MO - Macao, regione amministrativa speciale della Cina 4
MU - Mauritius 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
CY - Cipro 3
ET - Etiopia 3
IR - Iran 3
LV - Lettonia 3
LY - Libia 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
BB - Barbados 2
BO - Bolivia 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
GR - Grecia 2
LK - Sri Lanka 2
NO - Norvegia 2
Totale 37.858
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.819
Ashburn 1.806
Singapore 1.646
Warsaw 1.601
Fairfield 1.135
Chandler 1.075
Dublin 1.022
Hong Kong 1.021
Seoul 682
Jacksonville 552
Woodbridge 519
San Jose 503
Cambridge 498
Seattle 463
Houston 457
Milan 414
Wilmington 412
Hefei 395
Beijing 379
Buffalo 304
Los Angeles 287
The Dalles 271
Ann Arbor 264
Princeton 241
Florence 221
Ho Chi Minh City 220
Munich 219
Boston 198
Dong Ket 193
Lauterbourg 192
Rome 184
Altamura 180
Council Bluffs 178
Hanoi 173
Mumbai 162
Lawrence 150
Tokyo 148
Helsinki 140
Dallas 134
Melbourne 133
Boardman 130
Moscow 126
New York 110
Medford 92
Shanghai 90
Kent 82
Bern 71
San Diego 66
Paris 61
Naples 57
São Paulo 57
Turku 54
Bologna 51
Abidjan 49
Phoenix 45
Turin 45
Clifton 43
Guangzhou 42
Redondo Beach 42
Norwalk 41
Frankfurt am Main 38
Jakarta 38
Washington 38
Izmir 36
Orem 36
London 34
Brussels 33
Falls Church 33
Montreal 32
Da Nang 31
Haiphong 30
Hillsboro 30
Lappeenranta 29
Verona 29
Barcelona 28
Figino 27
Philadelphia 27
Toronto 27
Andover 26
Chicago 26
Frankfurt Am Main 25
Baghdad 24
Bari 24
Genoa 24
Johannesburg 24
Palermo 24
Abuja 23
Bengaluru 22
Brooklyn 22
Tianjin 22
West Jordan 22
Chennai 21
San Francisco 20
Seongnam 20
Stockholm 20
Venice 19
Yubileyny 19
Atlanta 18
Miano 17
Denver 16
Totale 24.999
Salva come PNG Salva come JPEG
Nome #
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 422
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 408
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 359
The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR) 324
New Histamine-Related Five-Membered N-Heterocycle Derivatives as Carbonic Anhydrase I Activators 308
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 306
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 301
Novel functionalized organotellurides with enhanced thiol peroxidase catalytic activity 300
An easy one-step procedure for the synthesis of novel beta-functionalised tellurides 297
2-Benzylpiperazine: a new scaffold for potent human Carbonic Anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents. 278
N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR) 276
Amino acids as building blocks for carbonic anhydrase inhibitors 273
Design, synthesis and biological evaluation of stereo- and regioisomers of amino aryl esters as multidrug resistance (MDR) reversers 273
THE FROZEN ANALOG APPROACH IN MEDICINAL CHEMISTRY 261
1,3-oxathiolane muscarinic ligands modified at the cationic head. 255
1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps in Escherichia coli 253
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators 250
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 247
Design, synthesis and preliminary biological evaluation of new isoform-selective f-current blockers. 245
Binding Profiles of a Series of 2-Arylpropionic Acid Esters on Cloned Human Muscarinic Receptors Subtypes (m1-m5) and Their Relationship to Nootropic Activity 244
Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug-resistance (MDR) modulators 244
6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers 236
Metformin reacts directly with glucose following the Maillard reaction pathway 234
Arylamino Esters as P-Glycoprotein Modulators: SAR Studies to Establish Requirements for Potency and Selectivity 232
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 230
N,N-Bis(cyclohexanol) amine aryl esters inhibit P-glycoprotein as transport substrates 227
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 226
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 224
N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent Pgp-dependent multidrug resistance (MDR) inhibitors 220
13C NMR SPECTRA OF 1,3-OXATHIOLANE, 1,3-OXATHIOLANE-3-OXIDE AND 1,3-OXATHIOLANE-3,3-DIOXIDE DERIVATIVES 219
Design and synthesis of new potent N,N-bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents 214
Design, synthesis and preliminary biological evaluation of zatebradine analogues as potential blockers of the hyperpolarization-activated current 213
Dual P-glycoprotein and CA XII inhibitors: A new strategy to reverse the P-gp Mediated Multidrug Resistance (MDR) in cancer cells y 212
Synthesis and carbonic anhydrase activating properties of a series of 2-amino-imidazolines structurally related to clonidine 211
Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands 211
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 211
Energy resolved tandem mass spectrometry experiments for resolution of isobaric compounds: a case of cis/trans isomerism 211
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 208
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 208
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 207
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 207
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 206
SEMI-RIGID ANALOGUES OF THE CALCIUM ANTAGONIST VERAPAMIL: A MOLECULAR MODELLING STUDY 204
Design, synthesis and nootropic activity of new analogues of sunifiram and sapunifiram, two potent cognition-enhancers. 203
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 203
ISOMERIC N,N-BIS(CYCLOHEXANOL)AMINE ARYL ESTERS: THE DISCOVERY OF A NEW CLASS OF HIGHLY POTENT P-GLYCOPROTEIN (PGP)-DEPENDENT MULTIDRUG RESISTANCE (MDR) INHIBITORS 202
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 201
Aminoarylesters as multidrug resistance (MDR) reverting agents endowed with high potency and efficacy 197
Carbachol dimers as homobivalent modulators of muscarinic receptors 197
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 196
Design, synthesis and preliminary evaluation of a series of histone deacetylase inhibitors carrying a benzodiazepine ring 193
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR) 192
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 192
Synthesis and Enantioselectivity of the Enantiomers of PG9 and SM21, New Potent Analgesic and Cognition-Enhancing Drugs 190
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents 190
Recent advances in the discovery of Nicotinic acetylcholine receptor allosteric modulators 189
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 189
New phenylalkylamines as isoform selective HCN-Channels blockers 188
Design, synthesis and pharmacological evaluation of some frozen-analogues of DMPP 185
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 185
ERMS EXPERIMENTS FOR RESOLUTION OF ISOBARIC COMPOUNDS: A CASE OF CIS/TRANS ISOMERISM 183
Piperazines as nootropic agents: New derivatives of the potent cognition-enhancer DM235 carrying hydrophilic substituents 182
2- or 3-Substituted piperazines as nootropic agents: carbethoxy and hydroxymethyl analogues of the cognition-enhancer DM235 182
Design, synthesis and preliminary pharmacological evaluation of new piperidine and piperazine derivatives as cognition-enhancers 181
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators 181
N,N-bis(alkanol)amine aryl esters and N,N-bis(cyclohexanol)amine aryl esters: Idantification of a new class of Pgp-dependent multidrug resistance (MDR) reverters andowed with potencies in the nanomolar range 181
New dual P-Glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as Multidrug Resistance (MDR) reversers in cancer cells 180
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 178
Design of novel nicotinic ligands through 3D database searching 178
Chiral synthesis and pharmacological evaluation of the enantiomers of SM32, a new analgesic and cognition-enhancing agent. 178
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in Tissues 178
N-alkanol-N-cyclohexanol amine aryl esters: Multidrug resistance (MDR) reversing agents with high potency and efficacy 177
The medicinal chemistry of multidrug resistance (MDR) reversing drugs 177
P-glycoprotein and carbonic anhydrases hybrid inhibitors: a new strategy to reverse multidrug resistance (MDR) in cancer cells 177
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 176
"Synthesis and binding properties of photoactivable Biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein" 176
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 175
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 175
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators. 173
Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm 172
PRESYNAPTIC AUTO- AND HETERO-RECEPTORS IN THE CHOLINERGIC REGULATION OF PAIN 172
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy 172
SAR STUDIES ON THE POTENT AND SELECTIVE MUSCARINIC ANTAGONIST 2-ETHYLTHIO-2,2-DIPHENYLACETIC ACID N,N-DIETHYLAMINOETHYL ESTER 171
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 171
Design, synthesis and preliminary pharmacological evaluation of new analogues of DM232 (unifiram) and DM235 (sunifiram) as cognition modulators 170
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 170
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 170
Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors 169
ANTIAMNESIC ACTIVITY OF METOCLOPRAMIDE, CISAPRIDE AND SR-17 IN THE MOUSE PASSIVE AVOIDANCE TEST 168
The power of energy-resolved tandem mass spectrometry experiments for resolution of isomers: the case of drug plasma stability investigation of multidrug resistance inhibitors 168
Application of LEDA Algorithm for the characterization of Isomers in Simultaneous Degradation Study in Human Plasma by HPLC-MS/MS 166
VERAPAMIL ANALOGUES WITH RESTRICTED MOLECULAR FLEXIBILITY: SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF THE FOUR ISOMERS OF ALPHA-[1-[3-[N-[1-[2-(3,4-DIMETHOXYPHENYL)ETHYL]]-N-METHYLAMINO]CYCLOHEXYL]]-ALPHA-ISOPROPYL-3,4-DIMETHOXYBENZENEACETONITRILE 165
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 165
Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold 164
STRUCTURAL DEPENDENCE OF THE ALLOSTERIC INTERACTION OF SEMI-RIGID VERAPAMIL ANALOGUES WITH DIHYDROPYRIDINE-BINDING IN KITTEN HEART 163
Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers 163
In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug-resistance reverting agents 163
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 1. Tropic and 2-Phenylpropionic Acid Esters 162
Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent 162
The piperazine scaffold for novel drug discovery efforts: the evidence to date 161
Totale 21.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.563 53 196 102 57 40 51 74 99 51 52 347 441
2022/20234.097 389 619 190 315 321 787 537 249 426 23 131 110
2023/20241.768 57 181 264 93 116 353 54 398 31 65 78 78
2024/202510.688 379 1.078 683 1.463 3.009 1.649 191 677 523 254 381 401
2025/202611.724 1.321 1.666 1.111 718 1.244 518 1.390 551 732 660 302 1.511
2026/202734 34 0 0 0 0 0 0 0 0 0 0 0
Totale 38.224